{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33558712",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "05",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41416-020-01223-7"
    ],
    "Journal": {
      "ISSN": "1532-1827",
      "JournalIssue": {
        "Volume": "124",
        "Issue": "9",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "British journal of cancer",
      "ISOAbbreviation": "Br J Cancer"
    },
    "ArticleTitle": "Transforming the landscape of early cancer detection using blood tests-Commentary on current methodologies and future prospects.",
    "Pagination": {
      "StartPage": "1475",
      "EndPage": "1477",
      "MedlinePgn": "1475-1477"
    },
    "Abstract": {
      "AbstractText": [
        "Early cancer detection should lead to an overall stage shift, less-intensive treatments and better patient outcomes. Current recommended screening programmes are limited to a handful of individual cancers. A multi-cancer early detection test that simultaneously detects and localises multiple cancers could reduce the morbidity and mortality associated with cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-8206-5232"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA. Liu.Minetta@mayo.edu."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Minetta C",
        "Initials": "MC"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Cancer",
    "NlmUniqueID": "0370635",
    "ISSNLinking": "0007-0920"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Early Detection of Cancer"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Hematologic Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "prevention & control"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Rate"
    }
  ],
  "CoiStatement": "The Mayo Clinic was compensated for M.C.L.\u2019s advisory board activities for GRAIL, Inc."
}